• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Search
Skip to main content
Advertisement

Johnson & Johnson

  1. Business
  2. Pharmaceuticals
  3. Johnson & Johnson
A CEO contender left Johnson & Johnson. Was she penalized for saying she wanted to be a CEO? Fortune08:58
J&J rejected $19 billion baby powder cancer accord pitched by one of its ex-lawyers BNN Bloomberg07:27
Johnson & Johnson moves to disqualify Beasley Allen from talc leadership Law.com20:15
Johnson & Johnson to participate in the 42nd annual J.P. Morgan healthcare conference Business Wire (Press Release)16:16
Vanda pharmaceuticals acquires rights to multiple sclerosis drug from Johnson & Johnson's company Benzinga12:36
How much time off should you get to mourn? U.S. bosses extend grief leave Canoe12:33
J&j in immunology: “We plan to lead the orals market” Scrip Pharma Intelligence18:01

Latest News

In the last 7 days
J&J Hit With Suit Over Stelara Exclusivity Law36015:52 8-Dec-23
Intel, J&J and Fiscal Discipline Help Costa Rica Outpace Region BNN Bloomberg13:22 8-Dec-23
Vanda Buys US, Canadian Rights to J&J’s MS Drug Ponvory in $100M Deal BioSpace11:13 8-Dec-23
J&J Rejected $19 Billion Baby Powder Cancer Accord Pitched by One of Its Ex-Lawyers BNN Bloomberg07:27 8-Dec-23
Ex-J&J Lawyer Proposed $19 Billion Talc-Cancer Case Settlement Bloomberg Law07:22 8-Dec-23
Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference Business Wire (Press Release)16:16 7-Dec-23
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company Benzinga12:36 7-Dec-23
A CEO contender left Johnson & Johnson. Was she penalized for saying she wanted to be a CEO? Fortune08:58 7-Dec-23
J&J Cites ‘Progress’ Settling Baby Powder Cancer Cases Insurance Journal01:50 7-Dec-23
J&J In Immunology: “We Plan To Lead The Orals Market” Scrip Pharma Intelligence18:01 6-Dec-23
Johnson & Johnson’s prescription for growth Nasdaq14:25 6-Dec-23
Johnson & Johnson says it’s finally making ‘progress’ on disturbing cancer lawsuits Bellingham Herald13:48 6-Dec-23
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities Benzinga11:30 6-Dec-23
Eye on Pharma: Bevacizumab Update; Samsung Bioepis, J&J Settlement; Another EU Trastuzumab Center for Biosimilars07:18 6-Dec-23
His dad worked on the factory floor at Johnson & Johnson. Now he’s the CFO Fortune07:04 6-Dec-23
The Zacks Analyst Blog Highlights Johnson & Johnson, T-Mobile US, Caterpillar, Broadcom and Starbucks Zacks04:00 6-Dec-23
Johnson & Johnson Moves to Disqualify Beasley Allen From Talc Leadership Law.com20:15 5-Dec-23
J&J says it has settled some talc claims, will continue bankruptcy strategy Reuters18:35 5-Dec-23
J&J CEO Says Weight-Loss Drug Market Is Too Crowded to Enter BNN Bloomberg18:32 5-Dec-23
J&J’s Growth Plan Calls For Mega-Blockbusters And A Leading Oncology Franchise Scrip Pharma Intelligence17:35 5-Dec-23
J&J forecasts 2024 sales growth of up to 6% Proactive Investors (US)11:55 5-Dec-23
Johnson & Johnson sees 2024 sales growth slowing as top drug faces rivals The Business Standard11:51 5-Dec-23
Johnson & Johnson to Settle More Cases Over Baby Powder That Allegedly Causes Cancer The Messenger11:32 5-Dec-23
J&J pitches investors on sales growth from cancer, immune disease drugs BioPharma Dive11:31 5-Dec-23
J&J Expects Up to 6% Growth Next Year with 20-Plus New Drugs by 2030 BioSpace11:22 5-Dec-23
Publication in Bloomberg Law: ‘A Third J&J Bankruptcy Attempt Won’t Resolve Victims’ Talc… Business Wire (Press Release)10:46 5-Dec-23
J&J Pushing to Settle Baby Powder Cases Linked to Asbestos (1) Bloomberg Law10:35 5-Dec-23
Johnson & Johnson (NYSE:JNJ) Shares Key Long Term Growth Drivers TipRanks09:29 5-Dec-23
Johnson & Johnson Ticks Higher Following Guidance Release Barron's Online08:10 5-Dec-23
Johnson & Johnson Targets Sales Growth in Years Ahead The Wall Street Journal08:04 5-Dec-23
J&J Sees 2024 Sales Growth Slowing as Top Drug Faces Competition BNN Bloomberg07:41 5-Dec-23
STAT Plus: J&J to emphasize cancer drugs and stop much of its vaccine research STAT07:27 5-Dec-23
Johnson & Johnson forecasts as much as 6% sales growth in 2024 Reuters07:23 5-Dec-23
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review Johnson & Johnson (Press Release)07:16 5-Dec-23
JNJ-86974680 by Johnson & Johnson for Non-Small Cell Lung Cancer: Likelihood of Approval Pharmaceutical Technology01:03 5-Dec-23
Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Seeking Alpha00:57 5-Dec-23
Johnson & Johnson pushes to settle baby powder cases linked to asbestos The Seattle Times00:29 5-Dec-23
The succession race is on at Johnson & Johnson, after the abrupt departure of a top executive… The Wall Street Journal00:27 5-Dec-23
Niraparib by Johnson & Johnson for Metastatic Castration-Resistant Prostate Cancer (mCRPC):… Pharmaceutical Technology23:32 4-Dec-23
J&J Is Pushing to Settle Baby Powder Cases Linked to Asbestos BNN Bloomberg22:31 4-Dec-23
Johnson & Johnson’s Investigational TAR-200 Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of… Johnson & Johnson (Press Release)17:33 4-Dec-23
Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc. GlobeNewswire (Press Release)16:20 4-Dec-23
J&J, Ethicon Settle 224 Hernia Mesh Defect Suits In MDL Law36015:50 4-Dec-23
Buffett Just Sold Dividend Kings Johnson & Johnson And Procter & Gamble - Buy This One Instead Seeking Alpha13:01 4-Dec-23
How much time off should you get to mourn? U.S. bosses extend grief leave Canoe12:33 4-Dec-23
Death of J&J Executive’s Teenage Son Prompts Big Policy Change Bloomberg Law09:39 4-Dec-23
Thinking about buying stock in Johnson & Johnson, Fortress Biotech, MicroStrategy, Neximmune,… PR Newswire (Press Release)09:35 4-Dec-23
J&J Hires Thousands, Invests Millions in AI-Powered Drug Discovery BioSpace08:14 4-Dec-23
How Much Time Off Should You Get to Mourn? Bosses Extend Grief Leave BNN Bloomberg06:12 4-Dec-23
The Executives Who Could Be Johnson & Johnson's Next CEO The Wall Street Journal05:38 4-Dec-23
Eight Limerick students awarded prestigious STEM scholarships Limerick Post11:12 3-Dec-23
Warren Buffett Just Closed His Position in This Dividend Giant. Should You? The Motley Fool05:39 3-Dec-23
In the last month
Barron's Weekend Stock Picks: Uber Joins The S&P 500, Schwab Rebounds And What's Next for Johnson & Johnson? Benzinga19:16 2-Dec-23
Stocks To Watch: Big Week On Tap For McDonald's, Shopify, GameStop, And Johnson & Johnson Seeking Alpha10:04 2-Dec-23
J&J MedTech Buys Heart Device Maker Laminar In $400M Deal Law36017:08 1-Dec-23
Johnson & Johnson Stock Gains a Bull Ahead of Analyst Day Barron's Online12:26 1-Dec-23
GSK, AstraZeneca, Johnson & Johnson and others raided in Turkish labour market probe Global Competition Review11:31 1-Dec-23
Johnson & Johnson bets heavy on AI-driven drug discovery STAT09:29 1-Dec-23
Johnson & Johnson transition underway, UBS assesses upcoming analyst day Investing.com09:10 1-Dec-23
Johnson & Johnson Medtech Acquires Laminar, for $400M FinSMEs08:21 1-Dec-23
Johnson & Johnson MedTech acquires heart implant company Laminar for $400m Verdict Medical Devices07:21 1-Dec-23
J&J MedTech buys medical device firm Laminar for $400m NS Medical Devices05:06 1-Dec-23
Johnson & Johnson Names Eugene Woods as Board Member MarketWatch17:47 30-Nov-23
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its… Business Wire (Press Release)16:31 30-Nov-23
Johnson & Johnson: Sleep Well At Night With The Only AAA-Rated Dividend Aristocrat Seeking Alpha16:00 30-Nov-23
Johnson & Johnson (NYSE:JNJ) Revised Earnings Don’t Balk Investors TipRanks12:08 30-Nov-23
Samsung Bioepis, J&J Ink Settlement and License Agreement for Stelara Biosimilar BioSpace11:48 30-Nov-23
Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way Johnson & Johnson (Press Release)09:30 30-Nov-23
Johnson & Johnson Buys Laminar For $400 Million, Trims Profit Outlook MarketWatch09:14 30-Nov-23
Johnson & Johnson slips as Laminar acquisition prompts a profit outlook cut Investing.com09:14 30-Nov-23
Johnson & Johnson MedTech Acquires Laminar, Inc. Business Wire (Press Release)08:42 30-Nov-23
Cosmeceuticals Market to explore excellent development deals| ZO Skin Health, Biomylz, Johnson… Industry Today07:19 30-Nov-23
Medical Supplies Market is Booming Worldwide | Medtronic, Cardinal Health, Johnson & Johnson Industry Today03:53 30-Nov-23
Johnson & Johnson, Ben Graham, And Defensive Stocks Seeking Alpha17:04 29-Nov-23
BDA Appoints Matt Ferrari as Chief Operating Officer PR Newswire (Press Release)09:03 29-Nov-23
Johnson & Johnson highlights its preeminent leadership in hematology through differentiated blood cancer portfolio and… Johnson & Johnson (Press Release)09:01 29-Nov-23
Why Johnson & Johnson is a Top 25 Dividend Giant (JNJ) Nasdaq07:47 29-Nov-23
Notable Tuesday Option Activity: J, UNH, JNJ Nasdaq13:39 28-Nov-23
Global Baby Care Products Market Report 2023-2029 Featuring P&G, Kimberly Clark, Johnson &… Business Wire (Press Release)11:34 28-Nov-23
Executives From Leading Retail and Healthcare Companies Join GS1 US Board of Governors PR Newswire (Press Release)09:15 28-Nov-23
Berkshire Hathaway shifts portfolio, exits Procter & Gamble and Johnson & Johnson Investing.com23:52 27-Nov-23
Progress for Johnson & Johnson's lung cancer drug as extension submitted to EMA Outsourcing-Pharma.com09:45 27-Nov-23
'Significant' partnership announced between Leeds Teaching Hospitals NHS Trust and Johnson &… Yorkshire Post06:33 27-Nov-23
Leeds NHS and Johnson & Johnson MedTech develop new partnership Med-Tech Innovation03:37 27-Nov-23
Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio The Motley Fool07:18 26-Nov-23
Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying? The Motley Fool06:37 26-Nov-23
Hernia Mesh Devices Global Market Analysis Report 2023, with Coverage of Key Players Johnson &… PR Newswire (Press Release)12:31 24-Nov-23
South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs North Platte Telegraph07:25 24-Nov-23
Johnson & Johnson sees highest patent filings and grants during August in Q3 2023 Pharmaceutical Technology07:14 24-Nov-23
NHS and industry expertise combine in strategic agreement Health Estate Journal03:50 24-Nov-23
Leeds Teaching Hospitals and Johnson & Johnson MedTech to collaborate on innovation Clinical Services Journal12:55 23-Nov-23
Hospital trust teams up with healthcare business to support innovation ecosystem TheBusinessDesk.com09:07 23-Nov-23
Leeds Teaching Hospitals and Johnson & Johnson MedTech to drive forward health innovation for West Yorkshire Leeds Teaching Hospitals NHS Trust (Press Release)07:58 23-Nov-23
Nasal Drug Delivery Technology Market – Major Technology Giants in Buzz Again | Merck & Co.,… Industry Today04:13 23-Nov-23
Johnson & Johnson Vision unveils new lens, cataract surgery device in Korea Korea Biomedical Review03:13 23-Nov-23
Market Whales and Their Recent Bets on JNJ Options Benzinga15:04 22-Nov-23
Berkshire Hathaway divests from long-held stocks amid market shifts Investing.com14:28 22-Nov-23
IBM, Johnson & Johnson Hit With Second Health Data Breach Suit Bloomberg Law12:29 22-Nov-23
Stelara Biosimilar Tests Value Proposition in Drug Price Program Bloomberg Law05:12 22-Nov-23
Learning and development should be complemented by DE&I, says this author Silicon Republic02:03 22-Nov-23
Caren Kenney On The Five Things You Can Do To Become More Resilient During Turbulent Times Thrive Global20:16 21-Nov-23
Chinese Drug Co. Wants J&J Conspiracy Claim Tossed Law36020:03 21-Nov-23
STAT Plus: Sen. Bernie Sanders publicly pressures Merck, J&J, and Bristol Myers Squibb to… STAT12:55 21-Nov-23
A Third J&J Bankruptcy Attempt Won’t Resolve Victims’ Talc Claims Bloomberg Law04:35 21-Nov-23
Global Medical Devices Market Report 2023-2028. Featuring Profiles of Medtronic, Johnson &… PR Newswire (Press Release)12:30 20-Nov-23
Behind the Scenes of Johnson & Johnson's Latest Options Trends Benzinga12:13 20-Nov-23
Global Diaper Market Report Outlook to 2026, Featuring Profiles of Key Players Johnson & Johnson, Kimberly-Clark,… GlobeNewswire (Press Release)09:47 20-Nov-23
Thinking about trading options or stock in Meta Platforms, Johnson & Johnson, PENN… PR Newswire (Press Release)09:38 20-Nov-23
Medical Aesthetic Devices Market Set for More Growth | Johnson & Johnson, Allergan, Cynosure,… Industry Today07:12 20-Nov-23
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in… PR Newswire (Press Release)14:16 19-Nov-23
21 Analysts Have This to Say About Johnson & Johnson Benzinga15:14 17-Nov-23
Talc Lawyer: Johnson & Johnson Settlements Undermine Bankruptcy Strategy, Serve as… Business Wire (Press Release)12:08 17-Nov-23
Ethicon présente ETHIZIA™ Hemostatic Sealing Patch, cliniquement prouvé pour arrêter les… PR Newswire (Press Release)10:08 17-Nov-23
Johnson & Johnson Settles Two Talc Lawsuits The Messenger09:54 17-Nov-23
Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win? The Motley Fool06:09 17-Nov-23
view more headlines
8 Dec 15:52

Johnson & Johnson News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Johnson & Johnson news, covering the latest share price, vaccine news and more from the best online news publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
Read more

Pharmaceuticals Top Stories

US agency approves cure for Sickle Cell Disease Leadership, Nigeria16:17CRISPR/Gene Editing FDA Business (US)
U.S. FDA approves two gene therapies for sickle cell disease CTV News Edmonton12:11CRISPR/Gene Editing FDA Business (US)
US approves CRISPR gene-editing to treat sickle cell disease Deutsche Welle14:55CRISPR/Gene Editing FDA
FDA approves two gene therapies for sickle cell, bringing hope to thousands with the disease WHDH-TV, Massachusetts14:11CRISPR/Gene Editing FDA
AbbVie buys Cerevel Therapeutics for $8.7B, Bolstering neuroscience portfolio Investopedia15:29AbbVie Biotech Cerevel Therapeutics
AbbVie to acquire Cerevel Therapeutics for $8.7 Billion European Pharmaceutical Manufacturer05:48AbbVie Biotech Cerevel Therapeutics
New sickle cell Drug awaiting FDA approval met with mixed emotions Black Enterprise10:03CRISPR/Gene Editing FDA
FDA approves two sickle cell therapies, including the first CRISPR medicine The Guam Daily Post09:15CRISPR/Gene Editing FDA
Merck-Eisai uterine cancer drug combination fails first-line treatment study Proactive Investors (US)09:37Keytruda Merck & Co Eisai
MSD’s Keytruda and Eisai’s Lenvima fail in Phase III uterine cancer trial Pharmaceutical Technology09:34Keytruda Merck & Co Eisai

Business Top Stories

The S&P 500 just had 1 of its best months in history. Here's what the stock market usually does next The Motley Fool09:54Dow Jones S&P 500 Nasdaq
Be careful what you wish for: This event may signal the start of the 2024 bear market The Motley Fool05:09Dow Jones S&P 500 Nasdaq
Elon Musk reactivates Alex Jones' X accounts after a five-year ban CNBC09:47X (Twitter) Elon Musk Alex Jones
Elon Musk’s Grok Twitter AI is actually ‘Woke,’ hilarity ensues Forbes09:27X (Twitter) Elon Musk Alex Jones
Elon Musk says Ilya Sutskever—the OpenAI chief scientist who helped fire Sam Altman then… Yahoo! US07:59Sam Altman OpenAI AI
OpenAI’s Sam Altman was said to be psychologically abusive, Washington Post reports The Messenger11:16Sam Altman OpenAI AI
EU sets global precedent with comprehensive AI regulation deal ReadWriteWeb16:50AI IT ChatGPT
Europe seals world's first set of rules regulating artificial intelligence Fox News12:58AI IT ChatGPT
UPenn President Liz Magill has resigned, but antisemitism remains a problem on college campuses CNN Money06:19Antisemitism Business (US) Politics
The 4 key events that led to UPenn President Liz Magill’s resignation CNN (Video)10:51Antisemitism Business (US) Politics
Publication filters

Headline Density

Notifications

  • Unsubscribe from Breaking News
    Sorry, no headlines or news topics were found. Please try different keywords.